Ark Solutions Inc (KOSDAQ:203690)

Market Cap	68.91B
Revenue (ttm)	33.23B
Net Income (ttm)	-9.43B
Shares Out	15.57M
EPS (ttm)	-730.43
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	4,425.00
Previous Close	4,425.00
Day's Range	4,425.00 - 4,425.00
52-Week Range	3,815.00 - 10,380.00
Beta	1.15
RSI	28.88
Earnings Date	May 14, 2025

About Ark Solutions

Ark Solutions Inc. engages in the research and development of products using protein in South Korea, Japan, Mexico, and internationally. It operates through Life and Health Business and Exosome Business divisions. The company offers products using stem cells. The company also provides cosmetics for hospitals and clinics, such as AAPE, a products containing high concentration human cell culture medium that helps improve the skin and scalp; Cytovesicle, a product that contains cytocore and high-concentration human stem cell culture medium that re...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2005
• Employees: 55
• Stock Exchange: KOSDAQ
• Ticker Symbol: 203690

Financial Performance

In 2024, Ark Solutions's revenue was 33.23 billion, a decrease of -10.81% compared to the previous year's 37.25 billion. Losses were -9.43 billion, -61.11% less than in 2023.